Growth hormone, body composition and somatomedin C after treatment of acromegaly. 1988

A R McLellan, and J M Connell, and G H Beastall, and G Teasdale, and D L Davies
Department of Medicine, Western Infirmary, Glasgow.

Acromegaly is associated with abnormal indices of body composition (as determined by exchangeable sodium, exchangeable potassium and total body water estimations) which may be corrected by treatment. We related these indices of body composition to the attained growth hormone levels (mean of five daytime values) in 42 treated acromegalics. Somatomedin C was measured in 30 subjects. The mean duration of treatment was 7.7 years (range 1-26). Exchangeable sodium, potassium and total body water were significantly lowered by treatment. After treatment of acromegaly subjects whose growth hormone level was below 5 mU/l achieved normal body composition more often than those with higher levels. Growth hormone concentration of below 5 mU/l after treatment should be regarded as more appropriate index of control of acromegaly than the higher levels previously recommended.

UI MeSH Term Description Entries
D007016 Hypophysectomy Surgical removal or destruction of the hypophysis, or pituitary gland. (Dorland, 28th ed) Hypophysectomies
D007334 Insulin-Like Growth Factor I A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor. IGF-I,Somatomedin C,IGF-1,IGF-I-SmC,Insulin Like Growth Factor I,Insulin-Like Somatomedin Peptide I,Insulin Like Somatomedin Peptide I
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D001823 Body Composition The relative amounts of various components in the body, such as percentage of body fat. Body Compositions,Composition, Body,Compositions, Body
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000172 Acromegaly A condition caused by prolonged exposure to excessive HUMAN GROWTH HORMONE in adults. It is characterized by bony enlargement of the FACE; lower jaw (PROGNATHISM); hands; FEET; HEAD; and THORAX. The most common etiology is a GROWTH HORMONE-SECRETING PITUITARY ADENOMA. (From Joynt, Clinical Neurology, 1992, Ch36, pp79-80) Inappropriate Growth Hormone Secretion Syndrome (Acromegaly),Somatotropin Hypersecretion Syndrome (Acromegaly),Inappropriate GH Secretion Syndrome (Acromegaly),Hypersecretion Syndrome, Somatotropin (Acromegaly),Hypersecretion Syndromes, Somatotropin (Acromegaly),Somatotropin Hypersecretion Syndromes (Acromegaly),Syndrome, Somatotropin Hypersecretion (Acromegaly),Syndromes, Somatotropin Hypersecretion (Acromegaly)
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A R McLellan, and J M Connell, and G H Beastall, and G Teasdale, and D L Davies
July 1988, Calcified tissue international,
A R McLellan, and J M Connell, and G H Beastall, and G Teasdale, and D L Davies
January 1992, Annals of clinical and laboratory science,
A R McLellan, and J M Connell, and G H Beastall, and G Teasdale, and D L Davies
November 1984, The Journal of pediatrics,
A R McLellan, and J M Connell, and G H Beastall, and G Teasdale, and D L Davies
November 1981, The Journal of clinical endocrinology and metabolism,
A R McLellan, and J M Connell, and G H Beastall, and G Teasdale, and D L Davies
December 1986, The Journal of clinical endocrinology and metabolism,
A R McLellan, and J M Connell, and G H Beastall, and G Teasdale, and D L Davies
August 1986, Clinics in endocrinology and metabolism,
A R McLellan, and J M Connell, and G H Beastall, and G Teasdale, and D L Davies
January 1988, Psychoneuroendocrinology,
A R McLellan, and J M Connell, and G H Beastall, and G Teasdale, and D L Davies
December 1981, Endokrinologie,
A R McLellan, and J M Connell, and G H Beastall, and G Teasdale, and D L Davies
January 1998, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie,
A R McLellan, and J M Connell, and G H Beastall, and G Teasdale, and D L Davies
July 1988, The Journal of clinical endocrinology and metabolism,
Copied contents to your clipboard!